Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2025 · Mkt capMarket cap $33.17B · View financials
Snapshot Sep 4, 4:00 PM ET
FY 2025 · Mkt cap
Decision snapshot: DXCM stock price vs TT: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at TT's multiple
Needs TT P/E.
Implied fair value · at DXCM's multiple
Needs DXCM P/E.
Snapshot Sep 4, 4:00 PM ET
Metric by metric
Where each company leads, and how wide the gap is.
Growth edge
Pricing power
Operating leverage
Multiple premium
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: DXCM FY 2025 (ended Dec 31, 2025) · TT FY 2025 (ended Dec 31, 2025).
Trendline
Five fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Capital structure 91% equity / 9% debt · EV / Revenue 7.63x · EV / EBITDA 26.75x
Capital structure 95% equity / 5% debt · EV / Revenue 4.79x · EV / EBITDA 22.79x
TT carries the larger enterprise value at $102.09B against $35.57B; TT trades on the lower EV / Revenue multiple (4.79x vs 7.63x); TT on the lower EV / EBITDA (22.79x vs 26.75x).
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
DEXCOM, INC. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
TRANE TECHNOLOGIES PLC · implied price per share
Bear
$153.52
Base
$187.93
Bull
$235.37
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Debt / equity
Total debt against shareholders' equity
1.21x
0.62x
Net debt / EBITDA
Leverage against operating earnings
1.81x
0.79x
Cash and equivalents
Liquid reserves on the balance sheet
$917.70M
$1.76B
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
ABBOTT LABORATORIES
DXCM vs ABT
Medtronic plc
DXCM vs MDT
BECTON DICKINSON & CO
DXCM vs BDX
HONEYWELL INTERNATIONAL INC
DXCM vs HON
LENNOX INTERNATIONAL INC
DXCM vs LII
Johnson Controls International plc
DXCM vs JCI
Walt Disney Co
DXCM vs DIS
EMERSON ELECTRIC CO
DXCM vs EMR
SPX Technologies, Inc.
DXCM vs SPXC
$3.32B
$5.31B
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
